CORPORATE - 26-03-2018

Human Rabies - An Interview with Peter J. Costa MPH

Rabies Immune Globulin Brand Director at Kedrion Biopharma

read more 

CORPORATE - 12-02-2018

Global Maternal Health Milestone Reached: 50th Anniversary

U.S. Approval of RhoGAM®, Rho(D) Immune Globulin

read more 

EVENTS - 14-12-2017

KEDRAB™: Pivotal Phase 2/3 Data presented at RITA Conference

Kedrion Biopharma and Kamada Received FDA Approval of the Product in Q3 2017

read more 

CORPORATE - 25-08-2017

Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™

For Post-Exposure Prophylaxis Against Rabies Infection

read more 

Pages